More on NGNE
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $23.95 |
|
|||
| Open | $24.00 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $24.27 | ||||
| Day Low | $23.00 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 571,532 | ||||
- JPMorgan Starts Neurogene (NGNE) at Overweight
- Form SCHEDULE 13G Neurogene Inc. Filed by: PRUDENTIAL FINANCIAL INC
- Jennison Associates LLC reports 11.1% passive stake in Neurogene as of Sept 30 - SEC filing
- Form SCHEDULE 13G Neurogene Inc. Filed by: JENNISON ASSOCIATES LLC
- Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Form 4 Neurogene Inc. For: Sep 22 Filed by: McMinn Rachel
- Form SCHEDULE 13G/A Neurogene Inc. Filed by: Redmile Group, LLC
- Form SCHEDULE 13G/A Neurogene Inc. Filed by: Trails Edge Capital Partners, LP
- Form SCHEDULE 13G Neurogene Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
- Neurogene (NGNE) PT Lowered to $65 at H.C. Wainwright
Entities mentioned with NGNE
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- Definitive Agreement | View Related Stories »
- Stifel | View Related Stories »
- Earnings | View Related Stories »
- Show More...
